iLifeXtend Company Profile

Background

Company Overview

iLifeXtend is a biotechnology company specializing in personalized health solutions through advanced microbiome analysis and artificial intelligence (AI). Established in Singapore in June 2024, the company is dedicated to enhancing human health by leveraging the gut microbiome to develop innovative products and services.

Mission and Vision

The mission of iLifeXtend is to empower individuals worldwide with personalized health solutions by harnessing the power of AI and microbiome science. Their vision is to revolutionize personalized healthcare by integrating cutting-edge AI algorithms with comprehensive microbiome analysis, enabling individuals to achieve optimal health through tailored, data-driven interventions.

Primary Area of Focus

iLifeXtend focuses on providing personalized health solutions by analyzing the gut microbiome and offering customized dietary and supplement recommendations. Their services include advanced gut microbiome analysis, personalized nutrition guidance, and health monitoring and reporting.

Industry Significance

The company operates in the rapidly growing field of personalized healthcare, particularly emphasizing the gut microbiome's role in overall health. By integrating AI with microbiome science, iLifeXtend is at the forefront of a transformative approach to health and wellness.

Key Strategic Focus

Core Objectives

Personalized Health Solutions: Develop individualized health plans based on comprehensive microbiome analysis.

AI Integration: Utilize advanced AI algorithms to interpret complex microbiome data for precise health recommendations.

Global Health Impact: Provide accessible and effective health solutions to a global audience.

Specific Areas of Specialization

Gut Microbiome Analysis: Conduct in-depth assessments of gut bacteria to understand their impact on health.

Nutritional Guidance: Offer personalized food and supplement recommendations tailored to individual microbiome profiles.

Health Monitoring: Provide ongoing health parameter monitoring with detailed reports and insights.

Key Technologies Utilized

Artificial Intelligence: Employ AI-driven algorithms to analyze microbiome data and generate personalized health recommendations.

Next-Generation Sequencing: Utilize advanced sequencing technologies for comprehensive microbiome analysis.

Primary Markets Targeted

iLifeXtend targets health-conscious individuals globally, particularly those interested in personalized health solutions and proactive wellness management.

Financials and Funding

Funding History

As of December 2025, specific details regarding iLifeXtend's funding history, total funds raised, recent funding rounds, and notable investors are not publicly disclosed.

Intended Utilization of Capital

While specific utilization plans are not publicly detailed, it is anticipated that any raised capital would be directed towards:

Research and Development: Enhancing AI algorithms and microbiome analysis capabilities.

Product Development: Expanding the range of personalized health solutions offered.

Market Expansion: Increasing global reach and accessibility of services.

Pipeline Development

Key Pipeline Candidates

iLifeXtend's pipeline includes:

Personalized Nutrition Guide: An AI-powered algorithm that assesses the relationship between gut bacteria and health parameters to create optimal diet strategies.

Personalized Probiotic & Prebiotic Suggestions: A system that identifies suitable probiotic and prebiotic options based on individual gut profiles.

Stages of Development

Both pipeline candidates are in the development phase, with ongoing research and refinement to ensure efficacy and user satisfaction.

Target Conditions

The primary focus is on gut health-related conditions, including:

Irritable Bowel Syndrome (IBS): Affecting digestion and bowel habits.

Chronic Constipation: Persistent difficulty in bowel movements.

Anticipated Milestones

Specific timelines for product launches and clinical trials are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

AI-Powered Gut Health Solution: An advanced system that analyzes the gut microbiome to provide personalized health recommendations.

Significant Scientific Methods

Microbiome Analysis: Comprehensive assessment of gut bacteria using next-generation sequencing technologies.

AI Algorithms: Advanced machine learning models that interpret complex microbiome data for personalized health insights.

Leadership Team

Key Executives

Founder & CEO: Name not publicly disclosed.

Professional Backgrounds and Contributions

Specific details regarding the leadership team's professional backgrounds and contributions are not publicly disclosed.

Competitor Profile

Market Insights and Dynamics

The personalized healthcare market, particularly focusing on gut microbiome analysis, is experiencing significant growth. Consumers are increasingly seeking individualized health solutions, creating a dynamic and competitive landscape.

Competitor Analysis

While specific competitors are not publicly identified, companies in the personalized health and biotechnology sectors focusing on microbiome analysis and AI-driven health solutions are potential competitors.

Strategic Collaborations and Partnerships

As of December 2025, specific collaborations or partnerships have not been publicly disclosed.

Operational Insights

iLifeXtend differentiates itself through its AI-driven approach to gut health, offering personalized and scientifically-backed health solutions.

Strategic Opportunities and Future Directions

Strategic Roadmap

Product Expansion: Develop additional personalized health solutions based on microbiome analysis.

Global Outreach: Expand services to international markets to reach a broader audience.

Research Initiatives: Invest in ongoing research to enhance the understanding of the gut microbiome and its impact on health.

Future Business Directions

iLifeXtend aims to become a leader in personalized healthcare by continuously innovating and providing effective solutions that empower individuals to take control of their health.